1. Home
  2. PAYC vs PCVX Comparison

PAYC vs PCVX Comparison

Compare PAYC & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Paycom Software Inc.

PAYC

Paycom Software Inc.

HOLD

Current Price

$159.63

Market Cap

8.9B

Sector

Technology

ML Signal

HOLD

Logo Vaxcyte Inc.

PCVX

Vaxcyte Inc.

HOLD

Current Price

$47.81

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PAYC
PCVX
Founded
1998
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.9B
6.0B
IPO Year
2014
2020

Fundamental Metrics

Financial Performance
Metric
PAYC
PCVX
Price
$159.63
$47.81
Analyst Decision
Buy
Strong Buy
Analyst Count
14
7
Target Price
$223.08
$101.67
AVG Volume (30 Days)
793.6K
1.5M
Earning Date
02-11-2026
11-04-2025
Dividend Yield
0.91%
N/A
EPS Growth
N/A
N/A
EPS
8.05
N/A
Revenue
$2,001,300,000.00
N/A
Revenue This Year
$11.03
N/A
Revenue Next Year
$8.85
N/A
P/E Ratio
$20.55
N/A
Revenue Growth
9.72
N/A
52 Week Low
$156.50
$27.66
52 Week High
$267.76
$93.77

Technical Indicators

Market Signals
Indicator
PAYC
PCVX
Relative Strength Index (RSI) 38.75 59.46
Support Level $161.89 $42.40
Resistance Level $166.36 $48.65
Average True Range (ATR) 4.11 1.75
MACD 0.78 0.16
Stochastic Oscillator 8.60 92.34

Price Performance

Historical Comparison
PAYC
PCVX

About PAYC Paycom Software Inc.

Founded in 1998, Paycom is a human capital management software-as-a-service provider addressing customer requirements surrounding payroll, talent acquisition, talent management, HR management, as well as time and labor. The company primarily services midsize businesses within the United States, targeting businesses with 50-10,000 employees. The company primarily generates revenue through the sale of subscriptions providing access to its HCM platform. To a lesser extent, the company also generates revenue from implementation services provided to customers as well as interest income generated from customer funds. As of fiscal 2024, the company serviced slightly over 37,500 customers and stored data on over 7 million employees.

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

Share on Social Networks: